AlzeCure Pharma names Johan Sandin interim CEO as Martin Jönsson steps down

PUBT · 2d ago
AlzeCure Pharma names Johan Sandin interim CEO as Martin Jönsson steps down
  • AlzeCure Pharma CEO Martin Jönsson is stepping down. He has held the role since January 2020.
  • Johan Sandin, chief scientific officer, co-founder and former CEO, takes over today as interim CEO pending a permanent appointment.
  • Pontus Forsell, head of discovery and research, has been appointed deputy CEO.
  • The board will begin recruiting a permanent CEO.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzeCure Pharma AB published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.